Key Highlights

  • Alignment Healthcare (NASDAQ:ALHC) reported third quarter 2026 Revenue of USD 1.358 billion, up 36.7 percent, with health plan membership of about 301,200, up 31.2 percent.
  • The company posted a net loss of USD 8.1 million against income of USD 3.7 million, and adjusted EBITDA fell 32.8 percent to USD 21.8 million, a 1.6 percent margin.
  • The medical benefits ratio on an adjusted Gross Profit basis rose about 240 basis points to 89.5 percent, which management tied to higher medical trends than expected.
  • Fourth quarter guidance includes revenue of USD 1.316 billion and adjusted EBITDA of negative USD 28 million, and shares of Alignment Healthcare (NASDAQ:ALHC) fell roughly 11 percent on October 30, 2026.

Growth Outpaces Profit

The company release for the quarter ended September 30, 2026 shows rapid expansion alongside thin profit. Revenue rose from USD 993.7 million to USD 1,358.3 million. Adjusted gross profit grew 11.6 percent to USD 142.2 million, far slower than revenue, and loss from operations was USD 3.8 million. Alignment Healthcare (NASDAQ:ALHC) adds members faster than it adds profit because a Medicare Advantage insurer collects a fixed premium per member and then pays the medical bills, so higher costs per member reduce Margin directly.

What the Medical Benefits Ratio Reveals

The medical benefits ratio compares medical costs with premiums, so a 240 basis point rise means a larger share of each premium dollar went to care. The company cited Part D seasonality, the timing of clinical investments, elevated appeals and disputes, and higher costs in catastrophic and skilled nursing cases. Cost worries predate the report: at a Baird healthcare conference on September 15, 2026, executives discussed rising hospital and skilled nursing costs, and the shares fell 16 percent, hitting a 52 week low near USD 8.97 the next day, per published coverage. Chief executive John Kao attributed part of the pressure to a claims system transition, calling such implementations messy and noisy.

Guidance, Risks and What to Watch

Full-year guidance now calls for revenue of at least USD 5.245 billion, adjusted gross profit of at least USD 575 million, adjusted EBITDA of at least USD 100 million and membership of at least 305,000. Revenue and membership guidance were raised and profit guidance lowered, though prior profit figures were not in the release. The fourth quarter guide of adjusted EBITDA of negative USD 28 million compares with positive USD 21.8 million in the third quarter, a swing of about USD 50 million, simple arithmetic on two published numbers. The risks are medical cost Inflation and Medicare Advantage rate policy. Investors will watch the medical benefits ratio. This is not a forecast.

Where Things Stand

The insurer is Alignment Healthcare (NASDAQ:ALHC), and the guided fourth quarter adjusted EBITDA loss of USD 28 million shows that growth is arriving faster than profit. Revenue is up 36.7 percent and membership 31.2 percent, but the medical benefits ratio rose to 89.5 percent and profit guidance was lowered. The balance of evidence is that the Business model can scale, while cost control remains unproven. The next catalysts are the fourth quarter report and the medical benefits ratio trend as claims processing settles.